Last $4.64 USD
Change Today -0.16 / -3.33%
Volume 1.3M
TXMD On Other Exchanges
Symbol
Exchange
NYSE Amex
Stuttgart
As of 8:04 PM 07/25/14 All times are local (Market data is delayed by at least 15 minutes).

therapeuticsmd inc (TXMD) Snapshot

Open
$4.75
Previous Close
$4.80
Day High
$4.78
Day Low
$4.61
52 Week High
03/6/14 - $9.01
52 Week Low
08/27/13 - $2.03
Market Cap
674.8M
Average Volume 10 Days
1.6M
EPS TTM
$-0.23
Shares Outstanding
145.4M
EX-Date
06/6/08
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for THERAPEUTICSMD INC (TXMD)

Related News

No related news articles were found.

therapeuticsmd inc (TXMD) Related Businessweek News

No Related Businessweek News Found

therapeuticsmd inc (TXMD) Details

TherapeuticsMD, Inc. operates as a women’s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

69 Employees
Last Reported Date: 03/5/14
Founded in 2008

therapeuticsmd inc (TXMD) Top Compensated Officers

Co-Founder, Chief Executive Officer and Direc...
Total Annual Compensation: $448.3K
President, Secretary and Director
Total Annual Compensation: $363.7K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $324.6K
Chief Strategy Officer and Executive Vice Pre...
Total Annual Compensation: $200.0K
Compensation as of Fiscal Year 2013.

therapeuticsmd inc (TXMD) Key Developments

TherapeuticsMD, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 01:30 PM

TherapeuticsMD, Inc. Presents at JMP Securities Healthcare Conference, Jun-24-2014 01:30 PM. Venue: The Westin New York Grand Central, 212 East 42nd Street, New York, NY 10017, United States. Speakers: Robert G. Finizio, Co-Founder, Chief Executive Officer and Director.

TherapeuticsMD, Inc. Launches the First Daily Chewable Prescription Prenatal Vitamins with FOLMAX

TherapeuticsMD, Inc. announced the availability of the newly reformulated vitaMedMD(R) branded prescription prenatal vitamin, vitaMedMD RediChew(TM) Rx, and the BocaGreenMD(R) generic prescription prenatal vitamin Prena1 Chew. vitaMedMD RediChew Rx and Prena1 Chew are small, vanilla flavored, chewable prenatal vitamin tablets that dissolve quickly and are taken once daily. Like vitaMedMD's vitaPearl and BocaGreenMD's Prena1 Pearl, the new vitaMedMD RediChew Rx and Prena1 Chew contain FOLMAX(TM), providing the combination of immediate and modified release folic acid. According to the Centers for Disease Control and Prevention (CDC), every 4 1/2 minutes a baby is born with a birth defect. vitaMedMD RediChew Rx and Prena1 Chew, and vitaPearl and Prena1 Pearl, are available by prescription only at chain, independent and mail order pharmacies throughout the United States. A national field sales team supports the marketing of the vitaMedMD brand products.

TherapeuticsMD, Inc. - Analyst/Investor Day

TherapeuticsMD, Inc. - Analyst/Investor Day

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TXMD:US $4.64 USD -0.16

TXMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TXMD.
View Industry Companies
 

Industry Analysis

TXMD

Industry Average

Valuation TXMD Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 66.8x
Price/Book 14.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 62.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THERAPEUTICSMD INC, please visit www.therapeuticsmd.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.